🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🏅 The CRF SET-10: Global Rankings are here! CRF proudly unveils the top 10 institutions advancing interventional cardiovascular medicine at #TCT2024. These global leaders are driving innovation and excellence in heart care. 🌍❤️ Congrats to the #SET10 for pushing the

✨ A unique moment at #TCT2024: Jeffrey W. Moses receives a lifetime achievement award, celebrating his extraordinary impact in interventional cardiology. His touching speech honored his family, his father, and his team. A beautiful celebration of his legacy, hosted by @CRFHeart.

#TCT2024 in case you missed it! EARLY TAVR meets primary endpoint driven by Unplanned CV Hospitalization. Also prevents ⬇️ QoL! bit.ly/EARLY_TAVR NEJM TCTMD

We discussed this observation on #CardioTwitter: several noted that administering a heparin bolus the ER (100 units/Kg, not max 4,000), rather than waiting until the cath lab, improves TIMI flow by the time the patient reaches the cath lab. This is now supported by an RCT!

Exciting insights, great discussion at #TCT2024 disruptive imaging session on right-#heartfailure 1) PAPi refines prognostic value of TAPSE/PASP in #TTEER by Guillaume Bonnet-#EuroTR-team 2) Liver-ECV on #MRI could be new marker of systemic congestion by João Cavalcante-team Cardiovascular Research Foundation

Now: Live from Mainz‼️@TCTconference #TCT2024 #MTEER in Atrial-MR w/ Philipp Lurz Edoardo Zancanaro MD #TRuf + #TGössler Sam Dawkins Vinay Badhwar Cardiovascular Research Foundation

🤔#TTEER or #TTVR for #TR-related right-#heartfailure❓ Matched analysis by Guido Ascione TCT Conference : 🎯TTVR: better TR ⬇️ 🎯No differences in 1-y death/HFH (~10%)‼️ Lots of ❓remain, but in absence of RCT - big 🦶forward 👀 out for the manuscript soon. #TCT2024 #LuxValve

🌟Great way to start at #PCRLV Main Arena: Innovation for transcatheter tricuspid interventions Azeem Latib Didier Tchetche Philipp Lurz RTHahnMD thomas modine PCRonline 🫀 🎯Live TTVR case with Evoque system 🎯 Recorded TTVR case with Cardiovalve presented by Rodrigo Estévez

Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation jamanetwork.com/journals/jama/… Philipp Lurz Julia Grapsa MD, PhD Cosyns Bernard @CHU

In this episode of IMPact podcast, listen to Edoardo Zancanaro MD @jgrapsa Alessia Gimelli Karl-Patrik Kresoja Karl-Philipp Rommel , discuss "Tricuspid regurgitation and heart failure: the fate of treated vs. untreated cohort in the percutaneous Era" bit.ly/45CztiA #Spotify -->

Renal Denervation (RDN) has emerged as the third pillar of HTN treatment, alongside meds & lifestyle. Given its role in reducing SNS overdrive, could it be a game-changer for HF? #HREV explores the evidence & future directions. (link.springer.com/article/10.100…) Philipp Lurz Marat Fudim, MD MHS

Join the revolution at #THT2025 on Tuesday Feb 11 2025 with exciting breakfast and lunch symposia on #Cardiometabolic disease and #AtrialShunts in #HFpEF 6:30 am for the early birds 12:15 pm for the rest Get your runners ready (no heels, I hear!)

🔥 #THT2025 is in full swing! The room is packed with attendees diving into the latest breakthroughs in #heartfailure research and treatments. Exciting sessions, cutting-edge insights — this is where #innovation happens! 🫀🚀 #CardioX #CardioTwitter #CardioEd #CardioResearch

#Interventional_Heart_Failure 1⃣What it is 2⃣How you train for it 3⃣Where it is heading Charting the Course for Careers in Interventional Heart Failure: Training, Challenges, and Future Directions sciencedirect.com/science/articl… MyJSCAI Richard Cheng Miguel Alvarez Villela Navin Kapur

🧵Renal Denervation (RDN) for Hypertension – A meta-analysis of 12 sham-controlled RCTs in EHJOpen Editor-in-Chief academic.oup.com/ehjopen/articl… @jennifer_rymer Rajesh V Swaminathan Manesh Patel Marat Fudim, MD MHS

Join leading experts at HFA Congress 2025 for this CME accredited session: "Interventions for heart failure: mitral, tricuspid, and atrial shunt therapies" Topics include: - The unmet need for structural interventions in HF - Clinical outcomes and strategies in atrial shunt

Determinants of Right Heart Hemodynamic Derangement in Patients with and Without Tricuspid Regurgitation Gianfranco Parati MD, FESC Denisa Muraru CosmoGodino Marat Fudim, MD MHS Antonio Sorropago Jean-Luc Vachiery 🫀 Sergio Caravita Michele Tomaselli Luigi #AHAJournals ahajrnls.org/3I9kSDU